Embecta Corp. (EMBC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

14.24

+0.08

(+0.56%)

At close: 04:00PM EDT

14.35

+0.11

(+0.77%)

After hours:

05:50PM EDT

Loading interactive chart...

GuruFocus.com
Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024
Detailed Analysis of Embecta's Financial Performance and Strategic Highlights
Simply Wall St.
Embecta Second Quarter 2024 Earnings: Beats Expectations
Embecta ( NASDAQ:EMBC ) Second Quarter 2024 Results Key Financial Results Revenue: US$287.2m (up 3.6% from 2Q 2023...
GlobeNewswire
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2024. "Our performance in the second quarter and fiscal first half of 2024 underscores the resiliency of our base business, as well as strong operational execution by our global team. Since our spinoff approximately two years ago, we've remained steadfast in delivering on